Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
American Oncology Network (AONC) operates a community-based oncology network that partners with independent oncology and hematology practices. Recurring company news covers practice additions, clinic openings, physician recruitment, and regional expansion across community cancer-care markets.
Company updates also address support services for partner practices, including in-house pharmacy, laboratory support, clinical trial access, back-office operations, and revenue-diversifying programs. News involving the network’s practices includes outpatient oncology services, infusion therapy, blood-disorder care, CAR T-cell therapy, bispecifics, radiopharmaceuticals, patient advocacy, and participation in community oncology policy and industry forums.
American Oncology Network (NASDAQ:AONC) appointed Ella Friedman as president, network operations, effective June 11, 2026. She brings over 25 years of healthcare leadership across oncology, specialty care and multi-site operations and will oversee practice operations, strategic growth, integrations and infrastructure development across AON’s national community oncology network.
American Oncology Network (NASDAQ:AONC) and nonprofit CanCare announced a nationwide partnership on June 11, 2026 to deliver whole-person cancer care. The collaboration connects community oncology patients and caregivers with one-to-one emotional support from trained survivor and caregiver volunteers, complementing AON’s advanced clinical treatment.
The program, offered at no cost, supports patients at all stages of the cancer journey via phone, email, text, or in person. It builds on pilot programs at four AON partner practices, where positive feedback from patients and care teams highlighted the value of integrated peer support.
American Oncology Network (NASDAQ:AONC) announced a national partnership with Colla Health to expand oncology-focused behavioral health support across its community practices. The program launches at Hematology Oncology of Indiana and Genesis Cancer and Blood Institute and is expected to reach all AON partner practices nationwide by the end of 2026.
American Oncology Network (NASDAQ:AONC) and partner practice Florida Oncology and Hematology announced the addition of Board-certified medical oncologist and hematologist Dr. Vitor Pastorini to the physician team in Fort Myers and Cape Coral.
FOH now has nine medical oncologists and 15 advanced practice providers across five Florida locations.
American Oncology Network (NASDAQ:AONC) announced that multiple research studies co-authored by its physicians and leaders were selected for presentation at the ASCO 2026 Annual Meeting, held May 29–June 2 in Chicago.
Topics span clinical trials, AI-driven registries, pharmacovigilance, health disparities, and large language model evaluation, underscoring AON’s role in community oncology research.
AON reports that its practices currently offer access to more than 150 clinical trials, bringing innovative treatment options to local communities.
Zangmeister Cancer Center, a partner of American Oncology Network (NASDAQ:AONC), has become an affiliate of Ohio State’s OSUCCC – James through The James Cancer Network. The collaboration expands community-based cancer care across central Ohio, including access to more than 500 clinical trials and advanced therapies.
Patients gain local access to subspecialized oncology and hematology expertise, CAR T-cell therapy, stem cell transplant evaluation, tumor-infiltrating lymphocyte (TIL) therapy and proton therapy at OSUCCC – James, while maintaining strong ties to community care teams.
Elkhart Hematology and Oncology (formerly Elkhart Clinic’s hematology and oncology practice) joined American Oncology Network (AONC) on May 5, 2026, expanding patient access to clinical trials and community-based cancer care. The practice will continue onsite infusion, centralized lab/pathology, specialty pharmacy, care coordination and financial counseling.
Dr. Ahsanul Haque and Charisse Prall, FNP-BC will continue to lead clinical services and are accepting new patients.
MidAmerica Cancer Care (AONC) announced that Dr. Syed Karim, a board-certified medical oncologist and hematologist, has joined the physician team and is accepting new patients at the Belton location.
Dr. Karim brings more than 10 years of clinical experience in the Kansas City area and completed fellowships at George Washington University and Georgetown University Hospital. For more information visit maccsp.com and AONcology.com.
The Center for Cancer and Blood Disorders (AONC) received authorization to administer FDA-approved CAR T-cell therapy and has begun treating its first community oncology patient in the Maryland-area clinic as of April 23, 2026. The program offers outpatient CAR T and bispecific therapy access across Maryland, Washington, D.C., and Northern Virginia, led by Dr. Ralph Boccia and a multidisciplinary CCBD team. CCBD previously ran four outpatient CAR T trials and three outpatient bispecific trials, and coordinates closely with local hospitals to manage monitoring, safety, and follow-up care.
American Oncology Network (NYSE:AONC) will speak at the 2026 Community Oncology Alliance Annual Conference, April 28-29 in Orlando. AON leaders will deliver 11 sessions on topics including CAR T, radiopharmaceuticals, clinical trials, payer data, patient advocacy and careers in community oncology. AON will exhibit at booth 207.